Hepatocellular Carcinoma

Sahin Lacin; Asif Rashid; Yun Shin Chun; Bruno Calazans Odisio; Eugene J. Koay; Reham Abdel-Wahab; Ahmed O. Kaseb

doi:10.1007/978-3-030-18890-0_13

Hepatocellular Carcinoma

Sahin Lacin, Asif Rashid, Yun Shin Chun, Bruno Calazans Odisio, Eugene J. Koay, Reham Abdel-Wahab, Ahmed O. Kaseb

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Worldwide, hepatocellular carcinoma (HCC) is the sixth most common cancer and the second most common cause of cancer mortality, with a very poor survival rate. Many factors increasing the risk of HCC are classified into two groups: preventable and non-preventable. Unfortunately, HCC incidence is steadily increasing throughout the world. Therefore, many different kinds of HCC treatment are being evaluated to establish the optimal modality, reduce the development of new tumors, and prevent recurrence after surgical resection or liver transplantation. Basically, the treatment options for HCC are categorized as surgical or nonsurgical. Surgical therapies encompass resection and liver transplantation, whereas nonsurgical therapies include ablation techniques, transarterial therapies, irradiation, and systemic therapy including chemotherapy and molecularly targeted therapy.

Original language	English (US)
Title of host publication	Textbook of Gastrointestinal Oncology
Publisher	Springer Science+Business Media
Pages	207-234
Number of pages	28
ISBN (Electronic)	9783030188900
ISBN (Print)	9783030188887
DOIs	https://doi.org/10.1007/978-3-030-18890-0_13
State	Published - Jan 1 2019

Keywords

Ablation
Hepatocellular carcinoma
Liver surgery
Molecularly targeted therapy
Radioembolization
Systemic chemotherapy
Transarterial chemoembolization

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-18890-0_13

Cite this

@inbook{591fce8d261842f5aae72b947539accd,

title = "Hepatocellular Carcinoma",

abstract = "Worldwide, hepatocellular carcinoma (HCC) is the sixth most common cancer and the second most common cause of cancer mortality, with a very poor survival rate. Many factors increasing the risk of HCC are classified into two groups: preventable and non-preventable. Unfortunately, HCC incidence is steadily increasing throughout the world. Therefore, many different kinds of HCC treatment are being evaluated to establish the optimal modality, reduce the development of new tumors, and prevent recurrence after surgical resection or liver transplantation. Basically, the treatment options for HCC are categorized as surgical or nonsurgical. Surgical therapies encompass resection and liver transplantation, whereas nonsurgical therapies include ablation techniques, transarterial therapies, irradiation, and systemic therapy including chemotherapy and molecularly targeted therapy.",

keywords = "Ablation, Hepatocellular carcinoma, Liver surgery, Molecularly targeted therapy, Radioembolization, Systemic chemotherapy, Transarterial chemoembolization",

author = "Sahin Lacin and Asif Rashid and Chun, \{Yun Shin\} and Odisio, \{Bruno Calazans\} and Koay, \{Eugene J.\} and Reham Abdel-Wahab and Kaseb, \{Ahmed O.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-18890-0\_13",

language = "English (US)",

isbn = "9783030188887",

pages = "207--234",

booktitle = "Textbook of Gastrointestinal Oncology",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Hepatocellular Carcinoma

AU - Lacin, Sahin

AU - Rashid, Asif

AU - Chun, Yun Shin

AU - Odisio, Bruno Calazans

AU - Koay, Eugene J.

AU - Abdel-Wahab, Reham

AU - Kaseb, Ahmed O.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2019

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Worldwide, hepatocellular carcinoma (HCC) is the sixth most common cancer and the second most common cause of cancer mortality, with a very poor survival rate. Many factors increasing the risk of HCC are classified into two groups: preventable and non-preventable. Unfortunately, HCC incidence is steadily increasing throughout the world. Therefore, many different kinds of HCC treatment are being evaluated to establish the optimal modality, reduce the development of new tumors, and prevent recurrence after surgical resection or liver transplantation. Basically, the treatment options for HCC are categorized as surgical or nonsurgical. Surgical therapies encompass resection and liver transplantation, whereas nonsurgical therapies include ablation techniques, transarterial therapies, irradiation, and systemic therapy including chemotherapy and molecularly targeted therapy.

AB - Worldwide, hepatocellular carcinoma (HCC) is the sixth most common cancer and the second most common cause of cancer mortality, with a very poor survival rate. Many factors increasing the risk of HCC are classified into two groups: preventable and non-preventable. Unfortunately, HCC incidence is steadily increasing throughout the world. Therefore, many different kinds of HCC treatment are being evaluated to establish the optimal modality, reduce the development of new tumors, and prevent recurrence after surgical resection or liver transplantation. Basically, the treatment options for HCC are categorized as surgical or nonsurgical. Surgical therapies encompass resection and liver transplantation, whereas nonsurgical therapies include ablation techniques, transarterial therapies, irradiation, and systemic therapy including chemotherapy and molecularly targeted therapy.

KW - Ablation

KW - Hepatocellular carcinoma

KW - Liver surgery

KW - Molecularly targeted therapy

KW - Radioembolization

KW - Systemic chemotherapy

KW - Transarterial chemoembolization

UR - https://www.scopus.com/pages/publications/105013389217

UR - https://www.scopus.com/inward/citedby.url?scp=105013389217&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-18890-0_13

DO - 10.1007/978-3-030-18890-0_13

M3 - Chapter

AN - SCOPUS:105013389217

SN - 9783030188887

SP - 207

EP - 234

BT - Textbook of Gastrointestinal Oncology

PB - Springer Science+Business Media

ER -

Hepatocellular Carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this